查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1992861

球囊導管市場：2026-2032年全球市場預測（按應用、產品類型、材質、最終用戶和直徑範圍分類）

Balloon Catheter Market by Application, Product Type, Material, End User, Diameter Range - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，球囊導管市場價值將達到 36.5 億美元，到 2026 年將成長至 39.3 億美元，到 2032 年將達到 59.1 億美元，複合年成長率為 7.10%。

主要市場統計數據
基準年 2025 36.5億美元
預計年份：2026年 39.3億美元
預測年份 2032 59.1億美元
複合年成長率 (%) 7.10%

一篇全面的說明，探討了不斷變化的臨床需求和治療過程如何重新定義球囊導管技術和治療環境。

目前球囊導管的發展現況取決於臨床需求、醫療設備的逐步創新以及不斷演進的診療路徑的交會點。近年來，臨床醫生和製造商緊密合作，致力於改善導管設計，以提高置入便利性、擴大可及血管範圍並提升手術安全性。隨著影像技術和輔助性治療的日益成熟，球囊導管的功能已不再局限於擴張血管腔；它們如今已成為藥物輸送、病變治療和目標血管重塑的平台。這些變化是由人口老化和慢性血管疾病盛行率上升等人口結構變化所驅動，導致多個專科的球囊導管手術量不斷增加。

材料創新、平台改進和影像技術的整合如何改變球囊導管治療的路徑和操作流程？

在球囊導管產業，突破性的變革正在加速提升設備效能，並增強其與臨床工作流程的互通性。材料科學的進步，特別是熱可塑性橡膠和高強度聚合物的進步，使得在保持爆破強度的同時實現導管的超薄設計成為可能，從而改善了導管在彎曲解剖結構中的導航性能。同時，快速交換平台的改進最佳化了單人操作流程中的導管操作，使特定手術在門診手術中心和專科診所的實施更加可行。除了硬體的改進之外，藥物塗層和藥物釋放型球囊技術的興起也降低了血管再阻塞，減少了對永久性植入的需求，並重塑了治療流程。

評估美國在 2025 年實施的累積關稅如何重組了整個球囊導管生態系統的供應鏈、製造地和採購方式。

美國自2025年起實施的累積關稅已在全球醫療設備零件供應鏈中造成明顯摩擦，其中包括球囊導管的原料和子組件。先前依賴跨境採購聚合物、導管軸和配件材料的製造商正面臨更高的接收成本，被迫重新評估供應商合約並調整總接收成本模型。為此，一些醫療設備製造商正在啟動近岸外包和在岸外包策略，以降低關稅風險並縮短前置作業時間。然而，這些轉型需要資本投入和重新認證，短期內可能會對營業利潤率造成壓力。

詳細的細分分析揭示了臨床應用、平台設計、材料、醫療環境和內徑規格如何驅動產品差異化和普及。

從臨床應用、器械結構、材料成分、終端用戶環境和尺寸範圍等角度進行詳細的市場細分分析，揭示了不同產品的獨特性能和擴散動態。就應用領域而言，心血管應用仍然是核心，包括冠狀動脈成形術和周邊心臟介入治療，這些手術需要精確的球囊順應性和輪廓控制。神經血管手術需要超低輪廓和軟性設計，以便穿過腦血管。頸動脈、下肢和腎動脈病變的周邊血管介入治療通常需要更大直徑和不同推播特性的球囊。此外，在泌尿系統應用中，生物相容性和扭矩控制是進入泌尿生殖系統的首要考慮因素。

美洲、歐洲、中東、非洲和亞太地區的需求模式和製造業實力差異如何影響各地區的商業化和生產策略？

球囊導管領域的區域趨勢是需求側臨床實務模式和供應側製造地共同作用的結果。在美洲，心血管和周邊血管介入治療量龐大，加之完善的醫保體系和成熟的醫院系統，推動了針對複雜解剖結構而開發的新型創新技術和器械的快速普及。商業環境強調全面的臨床證據和上市後註冊研究以支持產品的推廣應用，而進行特定球囊介入治療的門診診所也在不斷擴展。

策略競爭分析，描述了現有設備組合、專家創新者和製造合作夥伴如何透過合作和差異化來爭奪競爭優勢。

球囊導管領域的競爭格局呈現出多元化的特點，既有老牌醫療設備巨頭，也有專注於創新領域的專業企業，還有靈活敏捷的契約製造。市場參與企業在多個方面競爭，包括平台的多功能性、材料科學帶來的差異化優勢、臨床證據以及供應鏈的韌性。老牌製造商通常利用其廣泛的心血管產品組合來整合解決方案並構建一體化的手術方案，而專注於特定領域的企業則致力於突破性塗層、新型球囊形狀或超低輪廓輸送系統，以在特定的臨床細分市場中佔據主導地位。

為醫療設備製造商提供切實可行的策略建議，以確保供應鏈的韌性，加快證據的產生，並擴大在所有醫療保健機構中的應用。

產業領導者應優先考慮多管齊下的策略，以平衡短期業務永續營運和長期創新。首先，他們應重新評估並最佳化供應商網路，以降低關稅和前置作業時間風險。在條件允許的情況下，他們應認證多家材料供應商，並考慮在與需求中心相符的區域製造地。其次，他們應加大對材料和塗層的研發投入，以降低製造複雜性並維持臨床性能，同時設計具備快速切換和快速更換能力的平台，以滿足所有醫療機構的需求。

採用嚴謹的混合方法研究途徑，結合專家訪談、臨床文獻、醫療設備註冊和供應鏈分析，以檢驗策略見解。

為確保可靠性和有效性，本報告的研究採用了交叉檢驗的一手和二手調查方法。一手研究包括對介入性心臟病專家、介入神經放射學、血管外科醫生、醫院和門診手術中心的採購經理以及醫療設備製造商的研發和供應鏈主管進行結構化訪談。這些訪談提供了關於手術偏好、醫療設備性能權衡以及影響採購決策的因素的定性背景資訊。二級資訊來源包括同行評審的臨床文獻、醫療設備註冊資訊、監管文件、專利趨勢以及製造和材料技術概述，所有這些資料均用於支持一手研究的發現。

一份權威的綜合分析報告，重點闡述了醫療設備創新、供應鏈韌性和臨床證據之間的相互作用如何塑造未來的應用和治療結果。

總之，球囊導管領域正步入一個實踐創新期，其發展得益於材料技術的進步、平台的多功能性以及醫療服務環境的不斷演變。能夠將設計重點與實際手術流程和支付方期望相契合的製造商將獲得商業性優勢。同時，關稅和貿易趨勢等政策凸顯了供應鏈彈性和區域製造策略的重要性，促使企業在成本控制和持續投入實證醫學方面尋求平衡。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：球囊導管市場：依應用領域分類

  • 心血管系統
    • 冠狀動脈成形術
    • 周邊心臟治療
  • 神經血管
  • 周邊血管
    • 頸動脈
    • 下肢
    • 腎動脈
  • 泌尿系統

第9章：球囊導管市場：依產品類型分類

  • 越過電線
  • 快速交換

第10章：球囊導管市場：依材料分類

  • 尼龍
  • 佩巴克斯
  • 聚氨酯

第11章 球囊導管市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 依直徑範圍分類的球囊導管市場

  • 6毫米或以上
  • 3-6毫米
  • 小於3毫米

第13章 球囊導管市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 球囊導管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 球囊導管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國球囊導管市場

第17章：中國球囊導管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Acrostak AG
  • Alvimedica Medical Technologies Inc.
  • B. Braun Melsungen AG
  • Balton Sp. z oo
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Hexacath, Inc.
  • JOTEC GmbH
  • Medinol Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Oscor Inc.
  • QualiMed Innovative Medizinprodukte GmbH
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-1A1A064C008D

The Balloon Catheter Market was valued at USD 3.65 billion in 2025 and is projected to grow to USD 3.93 billion in 2026, with a CAGR of 7.10%, reaching USD 5.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.65 billion
Estimated Year [2026] USD 3.93 billion
Forecast Year [2032] USD 5.91 billion
CAGR (%) 7.10%

A comprehensive introduction exploring how clinical demand and care pathway evolution are redefining balloon catheter technology and procedural settings

The balloon catheter landscape sits at the intersection of clinical necessity, incremental device innovation, and evolving care pathways. Recent years have seen clinicians and manufacturers collaborate closely to refine designs that improve deliverability, expand vessel reach, and enhance procedural safety. As imaging modalities and adjunctive therapies mature, balloon catheters have become more than simple lumen-expanders; they function as platforms for drug delivery, lesion preparation, and targeted vessel remodeling. These shifts are driven by demographic realities, with aging populations and higher prevalence of chronic vascular conditions increasing procedural volumes across multiple specialties.

From a system perspective, the interplay between hospitals, ambulatory surgical centers, and specialty clinics is reshaping where and how balloon catheter procedures are performed. Payment models and care pathway optimization are steering straightforward interventions toward lower-cost sites while complex or high-risk cases remain concentrated in tertiary centers. Consequently, device designers face dual pressures: deliver robust clinical performance within constrained procedural times and adapt to the logistics and staffing profiles of a broader range of care settings. Taken together, the introduction underscores an era of precision-focused device evolution anchored in real-world clinical needs and operational pragmatism.

How material innovation, platform refinement, and imaging integration are collectively reshaping adoption pathways and procedural practice in balloon catheter care

Across the balloon catheter sector, transformative shifts are accelerating interoperability between device performance and clinical workflows. Advancements in materials science, particularly thermoplastic elastomers and high-strength polymers, have enabled thinner profiles with preserved burst strength, which in turn improve navigation through tortuous anatomy. Simultaneously, rapid exchange platform refinement has optimized catheter handling for single-operator workflows, making certain procedures more feasible in ambulatory surgical centers and specialty clinics. Parallel to hardware enhancements, the rise of drug-coated and drug-eluting balloon technologies has reframed treatment algorithms by reducing restenosis and limiting the need for permanent implants.

In tandem with clinical innovation, digitization and imaging integration are transforming pre-procedural planning and intra-procedural guidance. High-resolution intravascular imaging and enhanced fluoroscopic tools reduce reliance on operator experience alone, enabling broader adoption of advanced balloon techniques. Supply chain and manufacturing models are also shifting: there is increased vertical collaboration between polymer suppliers, contract manufacturers, and device OEMs to accelerate time to market and maintain quality control. Finally, regulatory pathways and post-market surveillance are becoming more dynamic, with real-world evidence playing a larger role in supporting expanded indications and reimbursement arguments. These combined forces are pushing the market toward greater specialization, modularity, and evidence-driven adoption.

Assessment of how cumulative U.S. tariffs introduced in 2025 reshaped supply chains, manufacturing footprints, and procurement behavior across the balloon catheter ecosystem

The imposition of cumulative tariffs in the United States beginning in 2025 has introduced measurable friction into global supply chains for medical device components, including balloon catheter raw materials and subassemblies. Manufacturers that previously relied on cross-border sourcing of polymers, catheter shafts, and ancillary materials have faced rising landed costs, prompting a reevaluation of supplier contracts and total landed cost modeling. In response, several device makers have initiated near-shoring and onshoring strategies to mitigate tariff exposure and shorten lead times, although such shifts require capital investment and requalification timelines that can compress operating margins in the near term.

Moreover, tariff-induced cost pressures have accelerated conversations about design-to-cost and material substitution, encouraging R&D teams to test alternative polymers and extrusion techniques that retain clinical functionality while lowering input costs. For healthcare providers, incremental price increases have influenced procurement behavior, with hospital purchasing groups negotiating more aggressively and ambulatory surgical centers weighing the value of premium device features against reimbursement realities. In sum, the tariff environment has not only affected pricing but has triggered strategic operational adjustments across manufacturing footprints, supplier relationships, and product development roadmaps, with consequences that will reverberate through procurement and clinical adoption decisions.

In-depth segmentation insights revealing how clinical application, platform design, materials, care settings, and diameter specifications drive product differentiation and adoption

Deep segmentation analysis uncovers distinctive performance and adoption dynamics when the market is viewed through clinical application, device architecture, material composition, end-user setting, and size range lenses. Application-wise, cardiovascular use remains a central focus, encompassing coronary angioplasty and peripheral cardiac interventions that demand precise balloon compliance and profile control; neurovascular procedures call for ultra-low profile and flexible designs to traverse cerebral vasculature; peripheral vascular interventions for carotid artery, lower limb, and renal artery lesions often require larger diameters and different pushability characteristics; and urology applications prioritize biocompatibility and torque control for genitourinary access.

From a product architecture perspective, over-the-wire platforms offer superior support and are preferred in complex or long lesions, whereas rapid exchange designs reduce procedure time and operator complexity, supporting diffusion into ambulatory settings. Material selection further stratifies performance: nylon provides predictable compliance and burst resistance; Pebax enables tunable flexibility and shaft stiffness gradients; and polyurethane offers abrasion resistance and patient comfort in certain anatomies. End-user segmentation shows distinct procurement drivers; hospitals focus on a broad portfolio to manage complex caseloads, ambulatory surgical centers emphasize efficiency and cost-per-case, and specialty clinics prioritize devices that simplify workflows for high-volume, low-complexity interventions. Diameter ranges also create product differentiation-above six millimeters necessitates robust tensile properties and balloon geometry optimized for larger vessel mechanics, three to six millimeters represents a high-volume clinical sweet spot across peripheral and cardiovascular domains, and up to three millimeters demands ultra-low profile construction and exceptional trackability for coronary and neurovascular insertions. Collectively, these segmentation lenses inform product R&D priorities, go-to-market strategies, and clinical training investments.

How distinct demand patterns and manufacturing strengths across the Americas, Europe Middle East and Africa, and Asia Pacific are shaping regional commercialization and production strategies

Regional dynamics in the balloon catheter field reflect a combination of demand-side clinical practice patterns and supply-side manufacturing concentrations. In the Americas, strong procedural volumes in cardiovascular and peripheral interventions are supported by established reimbursement frameworks and mature hospital systems, fostering rapid uptake of incremental innovations and device variants tailored to complex anatomies. The commercial environment favors comprehensive clinical evidence and post-market registries to support uptake, and ambulatory centers continue to expand the settings in which selected balloon interventions occur.

Across Europe, the Middle East, and Africa, variability in regulatory regimes and payer structures shapes market entry strategies and pricing negotiations. European markets place a premium on cost-effectiveness and robust clinical data, while certain Middle Eastern markets prioritize rapid access to novel technologies. In the Asia-Pacific region, a dual trend is apparent: manufacturing capability and supplier ecosystems have deepened, enabling scale and price competitiveness, while clinical adoption is accelerating in tertiary urban centers and select high-volume specialty hospitals. Emerging markets within the region exhibit increasing procedural volumes but require tailored value propositions for constrained healthcare budgets. These regional contrasts influence where companies locate production, how they structure clinical partnerships, and which product variants they prioritize for launch.

Strategic competitive analysis describing how established device portfolios, specialist innovators, and manufacturing partners are jockeying for advantage through alliances and differentiation

Competitive dynamics in the balloon catheter arena are characterized by a mix of legacy medical device leaders, specialized innovators, and agile contract manufacturers. Market participants are competing on multiple fronts: platform versatility, material science differentiation, clinical evidence, and supply chain resilience. Established manufacturers often leverage broad cardiovascular portfolios to bundle solutions and create integrated procedure offerings, while niche players concentrate on disruptive coatings, novel balloon geometries, or ultra-low profile delivery systems to win specialist clinical segments.

Strategic responses include targeted M&A to acquire complementary technologies, licensing agreements for proprietary polymer formulations or drug-eluting platforms, and partnerships with imaging and navigation providers to create combined solutions. Contract manufacturers and precision extrusion houses are gaining influence by enabling cost-effective prototyping and volume production, which lowers barriers for smaller innovators. Companies are also investing in lifecycle support-training programs, proctoring, and digital follow-up tools-to differentiate on clinical outcomes and physician experience. Overall, the competitive landscape rewards players who can synchronize technical differentiation with scalable manufacturing and evidence generation pathways.

Action-oriented strategic recommendations for device makers to secure supply chain resilience, accelerate evidence generation, and expand adoption across care settings

Industry leaders should prioritize a multi-dimensional strategy that balances near-term operational resilience with long-term innovation. First, reassess and optimize supplier networks to reduce tariff exposure and lead-time risk; where feasible, qualify multiple material suppliers and consider regional manufacturing nodes that align with demand centers. Second, direct R&D toward materials and coatings that preserve clinical performance while lowering manufacturing complexity, and concurrently design platforms that accommodate both over-the-wire and rapid exchange configurations to span care settings.

Third, invest in robust clinical evidence programs that address key payer concerns and demonstrate total cost of care benefits, particularly for adoption in ambulatory and specialty settings. Fourth, pursue flexible pricing and value-based contracting approaches to accommodate diverse reimbursement landscapes across regions. Fifth, strengthen partnerships with imaging and digital navigation vendors to enhance procedural success rates and physician preference. Finally, implement a structured market access playbook that aligns product portfolios by diameter range and clinical application, ensures targeted training and proctoring resources, and embeds supply chain contingencies into commercial forecasting. These coordinated actions will help organizations mitigate policy-driven cost shocks while accelerating sustainable adoption.

A rigorous mixed-methods research approach combining expert interviews, clinical literature, device registries, and supply chain analysis to validate strategic insights

The research underpinning this report integrates cross-validated primary and secondary methods to ensure robustness and relevance. Primary research involved structured interviews with interventional cardiologists, neurointerventionalists, vascular surgeons, procurement leaders from hospitals and ambulatory surgical centers, and senior R&D and supply chain executives from device firms. These conversations provided qualitative context on procedural preferences, device performance trade-offs, and procurement decision drivers. Secondary sources included peer-reviewed clinical literature, device registries, regulatory filings, patent landscapes, and manufacturing and materials technical briefs, all synthesized to corroborate primary findings.

Data triangulation was employed to validate thematic insights, with contradictory inputs reconciled through follow-up expert validation. The methodology also included scenario analysis to evaluate the operational implications of tariff changes and supply chain reconfiguration. Limitations are acknowledged: the analysis focuses on structural and technical trends rather than numerical market sizing, and regional heterogeneity can produce local variations that warrant targeted follow-up. Nonetheless, the approach yields actionable, evidence-based perspectives suitable for strategic planning and product development prioritization.

A conclusive synthesis emphasizing the interplay between device innovation, supply chain resilience, and clinical evidence in shaping future adoption and outcomes

In conclusion, the balloon catheter domain is undergoing a period of pragmatic innovation shaped by materials advances, platform versatility, and evolving care delivery settings. Manufacturers that align design priorities with real-world procedural workflows and payer expectations will gain commercial advantage. Simultaneously, policy and trade dynamics such as tariffs have highlighted the importance of supply chain agility and regional manufacturing strategies, prompting companies to balance cost containment with sustained investment in evidence generation.

Looking forward, success will depend on integrating technical differentiation-whether through material innovation, coatings, or delivery mechanics-with scalable manufacturing, targeted clinical studies, and tailored market access plans. Providers and device makers that collaborate on training, procedural standardization, and outcome measurement will be best positioned to demonstrate value and broaden the appropriate use of balloon catheter technologies across care settings. The cumulative effect will be a more resilient, evidence-driven marketplace that delivers improved patient outcomes while addressing operational and economic constraints.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Balloon Catheter Market, by Application

  • 8.1. Cardiovascular
    • 8.1.1. Coronary Angioplasty
    • 8.1.2. Peripheral Cardiac Procedures
  • 8.2. Neurovascular
  • 8.3. Peripheral Vascular
    • 8.3.1. Carotid Artery
    • 8.3.2. Lower Limb
    • 8.3.3. Renal Artery
  • 8.4. Urology

9. Balloon Catheter Market, by Product Type

  • 9.1. Over The Wire
  • 9.2. Rapid Exchange

10. Balloon Catheter Market, by Material

  • 10.1. Nylon
  • 10.2. Pebax
  • 10.3. Polyurethane

11. Balloon Catheter Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Balloon Catheter Market, by Diameter Range

  • 12.1. Above 6 Millimeters
  • 12.2. 3 To 6 Millimeters
  • 12.3. Less Than 3 Millimeters

13. Balloon Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Balloon Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Balloon Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Balloon Catheter Market

17. China Balloon Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Acrostak AG
  • 18.7. Alvimedica Medical Technologies Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Balton Sp. z o.o.
  • 18.10. Biosensors International Group, Ltd.
  • 18.11. Biotronik SE & Co. KG
  • 18.12. Boston Scientific Corporation
  • 18.13. Cardinal Health, Inc.
  • 18.14. Cook Medical LLC
  • 18.15. Endocor GmbH
  • 18.16. Hexacath, Inc.
  • 18.17. JOTEC GmbH
  • 18.18. Medinol Ltd.
  • 18.19. Medtronic plc
  • 18.20. Merit Medical Systems, Inc.
  • 18.21. MicroPort Scientific Corporation
  • 18.22. Nipro Corporation
  • 18.23. Oscor Inc.
  • 18.24. QualiMed Innovative Medizinprodukte GmbH
  • 18.25. Teleflex Incorporated
  • 18.26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BALLOON CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BALLOON CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BALLOON CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BALLOON CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BALLOON CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL CARDIAC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL CARDIAC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL CARDIAC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BALLOON CATHETER MARKET SIZE, BY CAROTID ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BALLOON CATHETER MARKET SIZE, BY CAROTID ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BALLOON CATHETER MARKET SIZE, BY CAROTID ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BALLOON CATHETER MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BALLOON CATHETER MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BALLOON CATHETER MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BALLOON CATHETER MARKET SIZE, BY RENAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BALLOON CATHETER MARKET SIZE, BY RENAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BALLOON CATHETER MARKET SIZE, BY RENAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BALLOON CATHETER MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BALLOON CATHETER MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BALLOON CATHETER MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BALLOON CATHETER MARKET SIZE, BY OVER THE WIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BALLOON CATHETER MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BALLOON CATHETER MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BALLOON CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BALLOON CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BALLOON CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BALLOON CATHETER MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BALLOON CATHETER MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BALLOON CATHETER MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BALLOON CATHETER MARKET SIZE, BY PEBAX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BALLOON CATHETER MARKET SIZE, BY PEBAX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BALLOON CATHETER MARKET SIZE, BY PEBAX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BALLOON CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BALLOON CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BALLOON CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BALLOON CATHETER MARKET SIZE, BY ABOVE 6 MILLIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BALLOON CATHETER MARKET SIZE, BY ABOVE 6 MILLIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BALLOON CATHETER MARKET SIZE, BY ABOVE 6 MILLIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BALLOON CATHETER MARKET SIZE, BY 3 TO 6 MILLIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BALLOON CATHETER MARKET SIZE, BY 3 TO 6 MILLIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BALLOON CATHETER MARKET SIZE, BY 3 TO 6 MILLIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BALLOON CATHETER MARKET SIZE, BY LESS THAN 3 MILLIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BALLOON CATHETER MARKET SIZE, BY LESS THAN 3 MILLIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BALLOON CATHETER MARKET SIZE, BY LESS THAN 3 MILLIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. GCC BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 146. GCC BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 147. GCC BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 167. G7 BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. G7 BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 170. G7 BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 171. G7 BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 175. NATO BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 178. NATO BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 179. NATO BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)